Schedule 13D ownership disclosure
COCRYSTAL PHARMA INC
Security class unavailable · CUSIP: 19188J102
Event date: 2014-11-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 272,955,522
- Percent of class
- 38.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-14-003817
- Form type
- SC 13D
- Filer
- Cocrystal Pharma, Inc.
- CIK
- CIK 1412486
- Filed
- Dec 05, 2014
- Reporting period
- Nov 25, 2014
- Description
- Schedule 13D beneficial ownership